These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 29168653

  • 1. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
    Goel A.
    Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
    [Abstract] [Full Text] [Related]

  • 2. The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay Goel.
    Goel A.
    Epigenomics; 2022 Mar; 14(6):345-349. PubMed ID: 35081730
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Making melanoma therapy personal: an interview with Dr Keiran Smalley for Melanoma Management.
    Smalley KS.
    Melanoma Manag; 2017 May; 4(2):95-97. PubMed ID: 30190911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cancer endocrinology through own experience: areas for further thought and development. Interview by Natasha Galukande.
    Berstein LM.
    Future Oncol; 2013 Jul; 9(7):933-7. PubMed ID: 23837755
    [Abstract] [Full Text] [Related]

  • 13. AURA3 trial: does Tagrisso (osimertinib) have the potential to become the new standard of care for second-line treatment of patients with EGFR T790M mutation-positive locally advanced or metastatic NSCLC.
    Papadimitrakopoulou VA.
    Lung Cancer Manag; 2016 Dec; 5(4):159-162. PubMed ID: 30643560
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The science of hope: an interview with Randy Jirtle.
    Jirtle RL.
    Epigenomics; 2022 Mar; 14(6):299-302. PubMed ID: 35264021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biomarkers for personalized medicine in GI cancers.
    Zhang SY, Zhang SQ, Nagaraju GP, El-Rayes BF.
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [Abstract] [Full Text] [Related]

  • 20. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.
    Haseltine WA.
    Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.